PharmaTher Advances Strategy to Build Next-Generation Ketamine Franchise for Neuropsychiatric Disorders; Secures Exclusive Rights to Evaluate and License Patent…

PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) (the "Company" or "PharmaTher"), a specialty life sciences company ...

PharmaTher Holdings Ltd.: PharmaTher Advances Strategy to Build Next-Generation Ketamine Franchise for Neuropsychiatric Disorders; Secures Exclusive Rights to Evaluate and ...

PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) (the "Company" or "PharmaTher"), a specialty life sciences company focused on unlocking the ...
TipRanks on MSN

PharmaTher Secures Rights to Long-Acting Ketamine Program for Neuropsychiatric Disorders

The latest announcement is out from PharmaTher Holdings Ltd ( ($TSE:PHRM) ). PharmaTher Holdings Ltd. has entered into an exclusive agreement with ...

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q3 2025 Earnings Call Transcript

Q3 2025 Earnings Call Transcript November 17, 2025 Operator: Good morning, ladies and gentlemen, and welcome to the NRx ...
PharmExec

Winners & Losers: What the First FDA Commissioner’s National Priority Vouchers Tell Us About Early Movers vs. Late Movers

The first wave of Commissioner’s National Priority Vouchers signals a fundamental shift in FDA competitiveness, rewarding companies that pair breakthrough science with affordability commitments, ...

NRx Pharmaceuticals, Inc. (NRXP) Q3 2025 Earnings Call Transcript

Q3 2025 Earnings Call November 17, 2025 8:30 AM ESTCompany ParticipantsMatthew Duffy - Chief Business Officer & ...

Microdosing this popular psychedelic for just 8 weeks can ease major depression: new study

New research suggests that microdosing a popular psychedelic may provide relief for people struggling with major depressive ...

Cybin Inc. (CYBN) Q2 2026 Earnings Call Transcript

Cybin Inc. ( CYBN) Q2 2026 Earnings Call November 13, 2025 8:00 AM EST ...